Efficacy and Safety of SYNB1934 in Patients With PKU (SYNPHENY-3)
Study sponsor: Synlogic
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-03-15Actual
Enrollment · participants35Actual
Source updated2024-06-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.